flashContent
Company news

02 November 2011

Alkor Bio represent the new diagnostic kit's line for Real-Time PCR analysis at the "Modern Hematology. Problems and Solutions" conference in Moscow

On the 2-3 of November biotechnological company from Saint-Petersburg- Alkor Bio- for the first time presented new diagnostic kit’s line for Real-Time PCR analysis in Moscow at the V theoretical and practical conference «Modern Hematology. Problems and Solutions».

01 November 2011

Test kits for diagnostics of hepatitis B - the latest innovative elaboration of Alkor Bio company

Two innovative elaborations of biotechnological group Alkor Bio – reagents kit «HepatitisIFA-HBsAg» aimed for qualitative & quantitative immunoenzymometric analysis of membrane antigen of hepatitis B & reagents kit «HepatitisIFA-HBsAg-confirming» aimed for immunoenzymometric conformation of antigen of hepatitis B virus – had at once gotten a registration certificate.

31 October 2011

"Vega" company entered the technological platform "Medicine of the future"

In 2011 one of the research units of the Alkor Bio Group  - «Vega» - entered the technological platform «Medicine of the future» together with the scientific-technical board «Molecular & cellular targets for diagnostics & therapy».«Medicine of the future» became the first officially settled technological platform in Russia. The organization works under the auspices of The Economic Development Department together with The Education and Science Department of Russian Federation.

21 October 2011

Chief executive of Alkor Bio Group is the holder of the "Chief of the year" business reward

Chief executive of Alkor Bio Group Dmitry Polyntsev became an honoree of the independent business reward «Chief of the year» in the category «Chief-Innovation-Manufacture». With the decision of the judging panel the winner of the category - Dmitry Polyntsev – was rewarded for the implementation of the new technologies & equipment into medical field as well as for the personal contribution into the support & of native elaborations.

12 October 2011

Vega Ltd. - the winner of the Contest for the best innovation project in science and higher education of the Saint-Petersburg

Vega Ltd. as a part of Alkor bio Group of Companies with its project “The development of microarray based diagnostic kit for simultaneously detection of allergen-specific IgE antibodies in human serum” became a winner of the Contest for the best innovation project in science and higher education of the Saint-Petersburg, 2011 in nomination “the best innovative idea in science”.

21 September 2011

Test kits for prenatal screening of Down's syndrome, Alkor Bio latest elaboration, had got the registration certificate

Latest elaborations of biotechnological group Alkor Bio – reagents kits “EIA-PAPP-A” & “GonadotropinEIA – free – hCG”, aimed for prenatal screening for Down’s syndrome in the 1 trimester of pregnancy, got the registration certificate of Federal Service on Surveillance in Healthcare and Social Development of Russian Federation.